Subpart D—FDA Review

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 1107
8. ›
9. Subpart D

Sections

Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.

• 1107.40
  § 1107.40 Communications between FDA and applicants.
• 1107.42
  § 1107.42 Review cycles.
• 1107.44
  § 1107.44 FDA action on an SE Report.
• 1107.46
  § 1107.46 Issuance of an order finding a new tobacco product substantially equivalent.
• 1107.48
  § 1107.48 Issuance of an order denying marketing authorization.
• 1107.50
  § 1107.50 Rescission of order.